Merck & Co., Inc. is 64.6x more valuable than AMICUS THERAPEUTICS, INC. by market capitalization ($294.13 B vs $4.55 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FOLD | MRK |
|---|---|---|
| Market cap | $4.55 B | $294.13 B |
| US-listed rank | #1468 | #44 |
| Revenue (latest FY) | $634.21M | $65.01B |
| Net income (latest FY) | -$27.11M | $18.25B |
| Net margin | -4.3% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 2,171 | 996 |
Merck & Co., Inc. is 64.6x more valuable than AMICUS THERAPEUTICS, INC. by market capitalization ($294.13 B vs $4.55 B).
In their latest fiscal years, AMICUS THERAPEUTICS, INC. reported $634.21M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: AMICUS THERAPEUTICS, INC. and Merck & Co., Inc., or browse the full rankings.